Search results for "Prostate Cancer"


 
Results 51 - 60 of about 141 for "Prostate Cancer".

Muddled mammography

There are two basic problems with cancer screening in general, problems that pertain as much or more to prostate cancer as to breast cancer. ... This is true of many prostate cancers as well, and the reason for formal recommendations against routine
June 2019

The fixation on a flawed cancer screening test

Preventive Services Task Force finding that prostate-specific antigen (PSA) screening for prostate cancer does more harm than good, the most frequent response I hear from physicians who continue to defend ... That's pretty much what we do by deploying
June 2019

FDA approves generic hypertension drugs, looks at Stalevo

because of shortages of propofol injection. The FDA is currently studying whether Stalevo, a Parkinson's disease medication, is associated with an increased risk for developing prostate cancer. ... Researchers unexpectedly found that more patients taking
June 2010

Even more studies you should ignore

That the connection to prostate cancer is unproven isn't a reason to take it. ... Too Much Fish Oil Might Boost Prostate Cancer Risk, Study Says (US News).
June 2019

The Medical Skeptic

Case in point: Screening for (and sometimes even treating) prostate cancer. ... Some people do die from prostate cancer. It's just that the science of knowing whom hasn't developed to where we'd like.).
June 2019

Is watchful waiting too difficult?

Watchful waiting" has been most discussed as a treatment strategy for prostate cancer. ... Treatment for prostate cancer, including radical prostatectomy, is fraught with side effects that may negatively impact quality of life.
June 2019

Letters to the Editor

disease, with the rationale being that perhaps we will detect an early ovarian cancer? ... prostate cancer, cannot.
March 2010

Guidelines should rarely become rules

Many clinical questions yield “competing guidelines.” We all know the controversies over breast cancer screening and prostate cancer screening.
June 2019

Ovarian cancer screening has no value

The furor over the lack of benefit for men of the screening Prostate Specific Antigen test (PSA) is still being heard. ... This is bad news because every year over 21, 000 women are diagnosed with ovarian cancer.
June 2019

Is cost-effective medicine on life support?

A few months back, The New York Times reported on two new drugs, approved by the FDA for cancer treatment. ... Provenge, a new drug for prostate cancer extends life by four months at a cost of $93, 000.
June 2019

Prev   1   2   3   4   5   6   7   8   9   10   Next